fierce pharma - Robuta Search

https://www.fiercepharma.com/ Fierce Pharma Biopharma News & Insights Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance. fierce pharma biopharma news insights https://www.fiercepharmaengage.com/ Home | Fierce Pharma Engage Tailored strategies for pharma success. Fierce Pharma Engage brings life sciences executives together in an intimate setting to collaborate and discover... fierce pharma engage https://www.fiercepharmaweek.com/ Home | Fierce Pharma Week Driving Pharma's Commercial Success. Fierce Pharma Week is your opportunity to enhance go-to-market approaches, drive commercial value, and gain insights from... fierce pharma week https://pharmamarketinginnovation.fiercepharmaengage.com/pharmamarketinginnovat/fierce-pharma-innovation-week-2026-registration?step=login Fierce Pharma Innovation Week 2026 Registration | Pharma Marketing Innovation innovation week 2026 fierce pharma registration marketing https://www.fiercebiotech.com/biotech/asco18-x4-pharma-s-i-o-combo-posts-23-orr-kidney-cancer ASCO: X4 Pharma's I-O combo posts 23% ORR in kidney cancer | Fierce Biotech Jun 1, 2018 - X4 Pharmaceuticals unveiled data on Saturday from the phase 2 expansion of a study testing its CXCR4 a https://www.fiercebiotech.com/biotech/dems-voting-no-on-prescription-drug-imports-receive-70-more-pharma-money Dems Voting No on Prescription Drug Imports Receive 70% More Pharma Money | Fierce Biotech Dec 17, 2009 - Dems Voting No on Prescription Drug Imports Receive 70% More Pharma Money BERKELEY, Calif. - December 16 - On Tuesday, December 15, the U.S. Senate voted... https://www.fiercebiotech.com/keyword/fosun-pharma Fosun Pharma | Fierce Biotech fosun pharma fierce biotech https://www.fiercebiotech.com/financials/ema-investigates-conflicts-of-interest-involving-officials-and-pharma EMA investigates conflicts of interest involving officials and pharma | Fierce Biotech Jul 6, 2012 - The European Medicines Agency has begun a probe into conflicts of interests at the organization having already been hit with complains about the "revolving... conflicts of interest ema investigates https://www.fiercebiotech.com/biotech/bristol-myers-snapping-up-amira-pharma-for-325m Bristol-Myers snapping up Amira Pharma for $325M | Fierce Biotech Jul 22, 2011 - Bristol-Myers Squibb ($BMY) has made a move to buy up potential drugs for lung disease and inflammation, agreeing to purchase venture-backed biotech Amira... bristol myers snapping amira pharma fierce https://www.fiercebiotech.com/keyword/kiadis-pharma Kiadis Pharma | Fierce Biotech pharma fierce biotech https://www.fiercebiotech.com/keyword/ascendis-pharma Ascendis Pharma | Fierce Biotech pharma fierce biotech https://www.fiercebiotech.com/r-d/pharma-fumbles-recruitment-game-as-clinical-trials-miss-goals Pharma fumbles in recruitment game as clinical trials miss goals | Fierce Biotech Jan 16, 2013 - Drugmakers and contract researchers keep coming back to the old ways of ushering patients into clinical trials, despite poor results in certain parts of the... in recruitment https://www.fiercebiotech.com/keyword/royalty-pharma Royalty Pharma | Fierce Biotech royalty pharma fierce biotech https://www.fiercebiotech.com/biotech/zs-pharma-raises-46-million-series-c-financing ZS Pharma raises $46 million in Series C Financing | Fierce Biotech Oct 24, 2012 - ZS Pharma raises $46 million in Series C Financing Capital to fund Phase III Clinical Trial targeting kidney and liver disease (FORT WORTH, Texas) October 23,... series c financing zs pharma raises 46 https://www.commondreams.org/news/2021/06/01/watchdog-shines-light-big-pharmas-fierce-eu-lobbying-campaign-against-vaccine-patent Watchdog Shines Light on Big Pharma's 'Fierce' EU Lobbying Campaign Against Vaccine Patent Waiver |... Jul 17, 2024 - "The public is being left in the dark as to the demands, influencing strategies, and full firepower of the Big Pharma lobby at a time when the debate over who... https://www.fiercebiotech.com/keyword/zs-pharma ZS Pharma | Fierce Biotech zs pharma fierce biotech https://www.fiercebiotech.com/keyword/athira-pharma Athira Pharma | Fierce Biotech athira pharma fierce biotech https://www.fiercebiotech.com/biotech/big-pharma-rivals-pfizer-and-novartis-team-up-nash-combo-targets Big Pharma rivals Pfizer and Novartis team up on NASH combo targets | Fierce Biotech Oct 29, 2018 - Pfizer is joining forces with Novartis with a throw it all at the wall and see what sticks approach as they look to combine NASH assets to see if it can beat... https://www.fiercebiotech.com/biotech/anji-pharma-secures-70m-series-b-for-phase-3-diabetes-asset-mid-stage-constipation Anji Pharma nabs $70M for late-stage diabetes treatment, ex-Novartis asset | Fierce Biotech Sep 28, 2021 - Anji Pharma wants to bring a Type 2 diabetes and chronic kidney disease treatment along with a constipation drug to market, and now the biotech has https://www.fiercebiotech.com/keyword/big-pharma Big Pharma | Fierce Biotech big pharma fierce biotech https://www.fiercebiotech.com/biotech/gw-pharma-gains-m-a-rumor-as-it-preps-for-fda-submission GW Pharma gains on M&A rumor as it preps for FDA submission | Fierce Biotech Sep 7, 2016 - GW Pharmaceuticals ($GWPH) gained about $500 million to hit $2.3 billion in market cap on rumors that it may soon be acquired.